awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36125906-7416E262-7075-40A0-A826-3BB7052627CC
Q36125906-7416E262-7075-40A0-A826-3BB7052627CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36125906-7416E262-7075-40A0-A826-3BB7052627CC
National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011.
P2860
Q36125906-7416E262-7075-40A0-A826-3BB7052627CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36125906-7416E262-7075-40A0-A826-3BB7052627CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47c32229adc04ce3a7202eb077bcab75d924ebc9
P2860
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.